Literature DB >> 32877552

Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia.

Melissa M Kim1, S Caitlin Conyngham1, Champagnae Smith1, Dana Higgins1, Tanner Nassau1, Coleman Terrell1, Kathleen A Brady1.   

Abstract

BACKGROUND: In 2018, Philadelphia identified an outbreak of new human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). Although conventional HIV surveillance systems capture individual-level behavioral risk, they are not able to capture the social and environmental factors contributing to rapid transmission.
METHODS: HIV surveillance data were used to assess demographic, clinical, and behavioral factors for PWID with HIV diagnosed during 2017 and 2018. Social factors such as homelessness, disruption of encampments, and trends in sexual behaviors, drug use and syringe availability among PWID were captured through National HIV Behavioral Surveillance, routine hepatitis and sexually transmitted infection surveillance, and shelter and homeless outreach data.
RESULTS: In 2018, there were 71 new infections among PWID, an increase of 115% since 2016. During this time, opioid overdose deaths peaked at 59 deaths per 100 000 persons, 85% of which involved the use of fentanyl. While overall reported homelessness increased, rates of those living unsheltered rose by 13%. The Philadelphia Department of Public Health identified increased injection frequency, encampment closures, and lack of syringe access as promoters of continued HIV transmission.
CONCLUSION: The use of conventional surveillance methods only is inadequate for determining HIV risk during outbreaks. Incorporation of individual and aggregate level data on social and environmental determinants is necessary to develop effective outbreak response interventions.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Outbreak Response; HIV Surveillance; Opioid epidemic; PWID; Social Determinants of Health

Mesh:

Year:  2020        PMID: 32877552     DOI: 10.1093/infdis/jiaa128

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

Review 1.  HIV Testing Strategies for Health Departments to End the Epidemic in the U.S.

Authors:  Kevin P Delaney; Elizabeth A DiNenno
Journal:  Am J Prev Med       Date:  2021-11       Impact factor: 6.604

2.  The CDC HIV Outbreak Coordination Unit: Developing a Standardized, Collaborative Approach to HIV Outbreak Assessment and Response.

Authors:  Alexandra M Oster; Anne Marie France; Robert P McClung; Kate Buchacz; Sheryl B Lyss; Philip J Peters; Paul J Weidle; William M Switzer; Stanley A Phillip; John T Brooks; Angela L Hernandez
Journal:  Public Health Rep       Date:  2021-05-28       Impact factor: 3.117

3.  Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study.

Authors:  Alexis M Roth; Nguyen K Tran; Marisa Felsher; Annette B Gadegbeku; Brogan Piecara; Rachel Fox; Douglas S Krakower; Scarlett L Bellamy; K Rivet Amico; Jose A Benitez; Barbara Van Der Pol
Journal:  J Acquir Immune Defic Syndr       Date:  2021-03-01       Impact factor: 3.771

4.  Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020.

Authors:  Melissa Perkins; Amber Slevin; Mark A Strand; Daniel Freisner
Journal:  Prev Chronic Dis       Date:  2021-07-15       Impact factor: 2.830

Review 5.  Social Determinants of Disease: HIV and COVID-19 Experiences.

Authors:  Raiza M Beltran; Ian W Holloway; Chenglin Hong; Ayako Miyashita; Luisita Cordero; Elizabeth Wu; Katherine Burris; Paula M Frew
Journal:  Curr HIV/AIDS Rep       Date:  2022-02-02       Impact factor: 5.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.